191 related articles for article (PubMed ID: 10904110)
21. Distribution of C3-step regulatory proteins of the complement system, CD35 (CR1), CD46 (MCP), and CD55 (DAF), in hematological malignancies.
Seya T; Matsumoto M; Hara T; Hatanaka M; Masaoka T; Akedo H
Leuk Lymphoma; 1994 Feb; 12(5-6):395-400. PubMed ID: 7514063
[TBL] [Abstract][Full Text] [Related]
22. Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies.
Hara T; Kojima A; Fukuda H; Masaoka T; Fukumori Y; Matsumoto M; Seya T
Br J Haematol; 1992 Oct; 82(2):368-73. PubMed ID: 1384649
[TBL] [Abstract][Full Text] [Related]
23. Evolutionary history of orthopoxvirus proteins similar to human complement regulators.
Ciulla E; Emery A; Konz D; Krushkal J
Gene; 2005 Aug; 355():40-7. PubMed ID: 16023794
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the active sites in decay-accelerating factor.
Kuttner-Kondo LA; Mitchell L; Hourcade DE; Medof ME
J Immunol; 2001 Aug; 167(4):2164-71. PubMed ID: 11490001
[TBL] [Abstract][Full Text] [Related]
25. Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter.
Murakami H; Nagashima H; Takahagi Y; Fujimura T; Miyagawa S; Okabe M; Seya T; Shigehisa T; Taniguchi N; Shirakura R; Kinoshita T
Transplant Proc; 2000 Nov; 32(7):2505-6. PubMed ID: 11120269
[No Abstract] [Full Text] [Related]
26. A study of human DAF, CD59, MCP transgene in xenotransplantation.
Chen S; Chen G; Cai CC; Wang XM; Guo H; Shen SQ; Wang H; Wu Y; Li GX; Huang J; Li WX; Wei QX; Sun FZ
Transplant Proc; 2001; 33(7-8):3851-2. PubMed ID: 11750639
[No Abstract] [Full Text] [Related]
27. A soluble chimeric complement inhibitory protein that possesses both decay-accelerating and factor I cofactor activities.
Higgins PJ; Ko JL; Lobell R; Sardonini C; Alessi MK; Yeh CG
J Immunol; 1997 Mar; 158(6):2872-81. PubMed ID: 9058824
[TBL] [Abstract][Full Text] [Related]
28. Structural gene for human membrane cofactor protein (MCP) of complement maps to within 100 kb of the 3' end of the C3b/C4b receptor gene.
Bora NS; Lublin DM; Kumar BV; Hockett RD; Holers VM; Atkinson JP
J Exp Med; 1989 Feb; 169(2):597-602. PubMed ID: 2521358
[TBL] [Abstract][Full Text] [Related]
29. Human complement regulators: a major target for pathogenic microorganisms.
Lindahl G; Sjöbring U; Johnsson E
Curr Opin Immunol; 2000 Feb; 12(1):44-51. PubMed ID: 10679403
[TBL] [Abstract][Full Text] [Related]
30. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.
Lublin DM; Coyne KE
J Exp Med; 1991 Jul; 174(1):35-44. PubMed ID: 1711565
[TBL] [Abstract][Full Text] [Related]
31. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors.
Fishelson Z; Donin N; Zell S; Schultz S; Kirschfink M
Mol Immunol; 2003 Sep; 40(2-4):109-23. PubMed ID: 12914817
[TBL] [Abstract][Full Text] [Related]
32. [Self- and non-self recognition mechanism via the complement system].
Okada N
Nihon Rinsho; 2005 Apr; 63 Suppl 4():279-83. PubMed ID: 15861669
[No Abstract] [Full Text] [Related]
33. Structural and functional characterization of a novel T cell receptor co-regulatory protein complex, CD97-CD55.
Abbott RJ; Spendlove I; Roversi P; Fitzgibbon H; Knott V; Teriete P; McDonnell JM; Handford PA; Lea SM
J Biol Chem; 2007 Jul; 282(30):22023-32. PubMed ID: 17449467
[TBL] [Abstract][Full Text] [Related]
34. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
35. Combining MAP-1:CD35 or MAP-1:CD55 fusion proteins with pattern-recognition molecules as novel targeted modulators of the complement cascade.
Pérez-Alós L; Bayarri-Olmos R; Skjoedt MO; Garred P
FASEB J; 2019 Nov; 33(11):12723-12734. PubMed ID: 31469600
[TBL] [Abstract][Full Text] [Related]
36. Complement regulatory proteins on human and porcine nontransgenic and hDAF transgenic islet cells: expression and role in susceptibility to lysis by human serum.
Bennet W; Sundberg B; Elgue G; Brendel M; Richards A; White DJ; Groth C; Korsgren O
Transplant Proc; 2000 Aug; 32(5):1066. PubMed ID: 10936358
[No Abstract] [Full Text] [Related]
37. The complement system in human reproduction.
Vanderpuye OA; Labarrere CA; McIntyre JA
Am J Reprod Immunol; 1992; 27(3-4):145-55. PubMed ID: 1384536
[TBL] [Abstract][Full Text] [Related]
38. Expression of complement regulatory proteins on human eggs and preimplantation embryos.
Fenichel P; Donzeau M; Cervoni F; Menezo Y; Hsi BL
Am J Reprod Immunol; 1995 Feb; 33(2):155-64. PubMed ID: 7544131
[TBL] [Abstract][Full Text] [Related]
39. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
Cosio FG; Shibata T; Rovin BH; Birmingham DJ
Kidney Int; 1994 Oct; 46(4):986-92. PubMed ID: 7532249
[TBL] [Abstract][Full Text] [Related]
40. CD46 (membrane cofactor protein of complement, measles virus receptor): structural and functional divergence among species (review).
Seya T; Nomura M; Murakami Y; Begum NA; Matsumoto M; Nagasawa S
Int J Mol Med; 1998 May; 1(5):809-16. PubMed ID: 9852300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
